If you have Lisinopril, it will be necessary to verify. More than 32,000 boxes of this generic drug against hypertension and heart failure were recalled in France due to a “printing defect” on plates “which can induce a risk of overdose”, said the National Agency for Medicines (ANSM) on Tuesday.
The quality of the tablets marketed by the American laboratory Viatris “is not called into question” but “the registration present on the aluminum of the brochure can lend to confusion because it suggests that it is necessary to take several tablets certain days”, specifies the ANSM.
A case of overdose reported
In total, four Lisinopril lots dosed at 5 mg are affected (lots 8172295, 8189879, 8172296, 8192737), or 32,640 boxes, according to a count obtained from the ANSM.
-In the event of overdose, it is possible to feel fatigue, balance disorders, hypotension and “alteration of kidney function may occur”, warns the drug’s guardian. A case of overdose accompanied by an unworthy confusing state has been reported, according to the ANSM.
Our health file
Until new lots with compliant plates are “soon available”, no supply voltage in Lisinopril is planned following this recall, according to the agency, because “alternatives are available”. Other generics, such as Biogaran, Teva, Zentiva, Sandoz or Arrow offer this molecule, depending on the Vidal Data Database in France.
